Evado launches cloud application

Friday, June 28, 2013 02:09 PM

Evado, a developer of software for clinical trial research, has launched a cloud application to streamline clinical trials by allowing the management of information and complex data from a single-page, user-interface regardless of software, format or user device.

“Business functions have been segmented into numerous apps that operate independently of one another,” said Jennie Anderson, Evado’s co-founder and chief executive officer. “As a result, users must open multiple applications to complete a single business process or function and companies must upgrade apps on a regular basis."

By standardizing user access across a wide variety of computer environments, UniFORM allows users to access the same information, in the same format, regardless of whether they are using a smart phone, iPad, android, desktop or laptop.

Medical staff will have the information they need to care for patients at their fingertips, in one application, no matter what device they are using. They will be able to see patients' health information securely from anywhere, at any time, in any language.  

The UniFORM technology will first be available in the clinical trials and patient registry arena.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs